In HR−/HER2+ subgroups, the results of subgroups were consistent with those of HER2+ subgroups, except that IDC‐ILC subtype with lung metastasis showed no difference compared with bone metastasis (Table 4). This evidence concerns the gene ERBB2 and bone metastasis.